The San Diego Biotechnology Network is hosting Intellikine at this month’s biotech professional networking event, and Intellikine CEO Troy Wilson is scheduled to make a presentation about the company. Intellikine, which made news in July for raising a potential $51 million in venture capital funding, specializes in the development of innovative, small molecule drugs for the treatment of cancer, inflammation, and autoimmune diseases. More information and online registration is here.